Press "Enter" to skip to content

Covid vaccine expert group discusses creation of digital infrastructure – Times of India

NEW DELHI: The National Expert Group on Vaccine Administration for COVID-19 met for the first time on Wednesday and discussed the creation of a digital infrastructure for inventory management and delivery mechanism of the vaccine.
The meeting was chaired by Dr V K Paul, member Niti Aayog with secretary, ministry of health and family welfare, as the co-chair.
A statement from the Union ministry of health and family welfare said, “The expert group deliberated on conceptualisation and implementation mechanisms for creation of a digital infrastructure for inventory management and delivery mechanism of the vaccine including tracking of vaccination process with particular focus on last mile delivery.”
“They discussed broad parameters guiding the selection of COVID-19 vaccine candidates for the country and sought inputs from Standing Technical Sub-Committee of National Technical Advisory Group on Immunization (NTAGI). The group delved on the procurement mechanisms for COVID-19 vaccine, including both indigenous and international manufacturing along with guiding principles for prioritisation of population groups for vaccination,” the release said.
More on Covid-19
The expert group discussed the financial resources required for procurement of COVID-19 vaccine and the different options. Available options in terms of delivery platforms, cold chain and associated infrastructure for roll out of COVID-19 vaccination were also taken up.
Further, strategy and follow-up action on all possible scenarios to ensure equitable and transparent delivery of vaccine was deliberated upon. Issues related to vaccine safety and surveillance were taken up and strategy for community involvement through transparent information and awareness creation were discussed.
The press release added, “India’s support to its key neighbours and development partner countries for COVID-19 vaccines was deliberated upon. The expert group discussed that India will leverage domestic vaccine manufacturing capacity and will also engage with all international players for early delivery of vaccines not only in India but also in low and middle income countries.”
The committee also advised all the States not to chart separate pathways of procurement, it said.